News Highly Sensitive to Stock Price: Feb 09

State Bank of India

State Bank of India (SBI) reported strong Q3 FY26 results, with a 24.5% year-on-year rise in standalone net profit to Rs 21,028 crore, driven by higher income and improved asset quality. Net Interest Income (NII) grew 9% to Rs 45,190 crore, with the Gross NPA ratio declining to 1.57%. Total advances increased by 15.14% year-on-year.

KIMS

Operational numbers were below expectations in the quarter. Revenue for the quarter grew 29.2% YoY at Rs 997.7cr as against estimate of Rs 1018cr. EBITDA margin slipped 430bps YoY at 19.9% as compared to estimate of 21.5%. Net profit declined 39.8% YoY at Rs 53.4cr. Higher finance cost and depreciation impacted profitability in the quarter. Other Income was down 71% YoY at Rs 5.2cr. Finance cost surged 121% YoY at Rs 56.8cr. ARPOB per day increased 20.5% YoY and 10.3% QoQ at Rs 46,341. Company has planned expansion at Sulur hospital, from current 109 beds to 409 beds. It would entail a capex of Rs 300 crore. Company has also planned a new children’s hospital at KMCH main campus. It would set up a 300 bed facility with a capex of Rs 300 crore and is expected to be commercialized in the next 36 months. EPS for the quarter stood at Rs 1.33 and it was at Rs 4.97 for 9MFY26. At CMP, the stock trades at 38.5x FY28E EPS and 18.5x FY28E EV/EBITDA.

Kalyan Jewellers

Kalyan Jewellers India Ltd reported a sharp jump in its Q3 FY26 consolidated net profit, aided by strong revenue growth and inventory gains, even as the jewellery retailer absorbed a one-time hit linked to the implementation of the new labour codes. The company’s Q3FY26 net profit rose 90% YoY to Rs 416.3 crore. Revenue from operations increased 42% on-year to Rs 10,343.4 crore during the quarter, reflecting robust demand and store-led growth

Sonata Software Ltd Q3FY26 results: Review

Sonata Software’s revenue was above expectations, and underperformed in profitability in Q3FY26. delivered a seasonally strong quarter in domestic business. The company remains optimistic about the long-term vision and growth prospects. Consolidated revenue stood at Rs 2,119 crore and grew by 45.4% QoQand 8.4% YoY in Rupee terms. EBIT rose 18.6% QoQ and 32.3% YoY to Rs 174 crore, and EBIT margin stood at 5.6% in Q3FY26 vs. 6.9% in Q2FY26 and 4.6% in Q3FY25. Net profit was down by 13.2% QoQand 0.6%YoY at Rs 104 crore in Q3FY26, impacted by one time costs due to new labour code.

Mahanagar Gas Ltd (MGL) Q3FY26 results: Review

MGL’s numbers were above expectations in Q3FY26. However, profitability was impacted due to the higher costs of natural gas on account of lower APM gas allocation. Net revenue grew by 11.5% YoY to Rs 2,060 crore in Q3FY26. EBITDA rose 8.4% YoY, stood at Rs 352 crore in Q3FY26 and EBITDA margin stood at 17.1% in Q3FY26 vs. 17.6% in Q3FY26, margin impacted due to higher costs of natural gas. Net Profit slipped 9.8% YoY to Rs 201 crore in Q3FY26 and PAT margin stood at 9.8% in Q2FY26 vs. 12.1% in Q3FY26. Revenue/EBITDA and PAT grew +0.5%/+4.2% and +5.1% QoQ, respectively

Oil and Gas

India’s government has extended the bid deadline for its largest oil and gas acreage offering. Potential investors now have until May 29, 2026, to submit bids. This is the fourth extension for OALP Bid Round X. The move allows more time for investors to study new liberalised rules. This round offers the largest area for exploration and production to date

Sudeep Pharma

Overall result was strong in the quarter. Revenue for the quarter grew 49.2% YoY at Rs 172.3cr. EBITDA margin improved 75bps YoY at 34.8%. Operating profit was up 52.5% YoY at Rs 60cr. Net profit increased 65.4% YoY at Rs 47.5cr. Other Income surged 181% YoY at Rs 6.85cr. During the quarter, the company conducted the groundbreaking ceremony for Battery Chemicals Plant at Dahej, with a planned Phase I capacity of 25,000 MT per annum, marking an entry into next generation energy materials. EPS for the quarter stood at Rs 4.29 and it was at Rs 11.32 for 9MFY26. At CMP, the stock trades at 28.5x FY28E EPS.

Godrej Agrovet Developed

Godrej Agrovet Limited (Godrej Agrovet), one of India’s leading diversified agribusinesses, has launched a new insecticide TAKAI, developed for rice crops. Powered by Cyclapryn technology by ISK Japan, TAKAI is effective against key rice pests, Stem Borer and, also controls Leaf Folder. When applied at a dose of 160 ml at 15-30 Days After Transplant (DAT) and again at 40-60 DAT, it provides an extensive protection window for the rice crop. The company is in process of getting label approval in Maize, Chilli, Cabbage, Soybean, Chickpea and Sugarcane crops too for TAKAI.

HBL Engineering

Revenue for the quarter increased 94% YoY at Rs 874cr. Operating profit surged 223% YoY at Rs 302.5cr. Other Income stood at Rs 10.5cr as compared to Rs 1.5cr in Q3FY25. Net profit increased 241.5% YoY at Rs 220.6cr.

Shilpa Medicare

Revenue for the quarter grew 28% YoY at Rs 411cr. Operating profit was up 40% YoY at Rs 115cr. Adj. net profit increased 72% YoY at Rs 55cr. API sales stood at Rs 186cr. Formulation business grew 52% YoY at Rs 177cr. Shilpa Medicare has filed its Rotigotine 1, 2, 3, 4, 6, 8 mg/24 h transdermal patch USP, ANDA for US market, marking its first-ever transdermal patch submission to the US FDA. EPS for the quarter stood at Rs 2.28 and it stood at Rs 6.9 for 9MFY26. At CMP,the stocktrades at 22x FY28E EPS.

Diffusion Engineers

Revenue for the quarter grew 27.3% YoY at Rs 100.8cr. EBITDA margin improved 25bps YoY at 13.4%. Operating profit was up 29.7% YoY at Rs 13.5 crore. Net profit increased 67.5% YoY at Rs 12.1cr. Other Income stood at Rs 3.5 crore vs. Rs 0.1 crore in Q3FY25. Order book stood at Rs 193.4 crore as of Dec-2025. EPS for the quarter stood at Rs 3.22 and it was at Rs 9.2 for 9MFY26. At CMP, thestock trades at 17x FY27E EPS.

Gujarat Alkalies

Overall numbers were slightly below expectations in the quarter. Revenue for the quarter grew 1.5% YoY at Rs 1044.5cr as against estimate of Rs 1117cr. EBITDA margin improved 50bps YoY at 10% as compared to estimate of 11%. Net loss stood at Rs 20cr as compared to net loss of Rs 11.2cr in Q3FY25. Other Income increased 101% YoY at Rs 30.5cr. At CMP, the stock trades at 16.5x FY27E EPS. Board has also approved installation of a 33870 TPA (85% H3P04) Food Grade Phosphoric Acid Plant at Dahej, Gujarat at an estimated project cost of Rs. 560 crore. Board has also approved installation of two Bio-fuel Coal fired boilers each at Vadodara and Dahej Complex (total 4 boilers) at an aggregate cost of Rs 389 crore. The said installations will substantially reduce the cost of steam, generate- 12 MW power and thus reduce overall cost of production.

Kovai Medical

Revenue for the quarter grew 14.6% YoY at Rs 407cr. EBITDA margin contracted 50bps YoY at 28.5%. Operating profit was up 12.7% YoY at Rs 116cr. Net profit increased 12.5% YoY at Rs 65cr. Other Income was up 20.2% YoY at Rs 7.2cr. EPS for the quarter stood at Rs 59.4 and it was at Rs 165.5 for 9MFY26. At CMP, the stock trades at 19.5x FY28E EPS and 13x FY28E EV/EBITDA.

Tata Steel

Tata Steel reported revenue of Rs.57,002 cr., up 6% year on year and down 3%quarter on quarter. It reported operating profit of Rs.8,200 cr. and margin of 14%. Its net profit stood at Rs.2,730 cr. from a profit of Rs.295 cr. in the previous year and a profit of Rs.3,183 cr. In previous quarter. Tata Steel delivered a strong performance in this quarter, with India crude steel production rising 12 per cent while deliveries grew faster at 14 per cent Y-o-Y, surpassing the 6 million tons mark in a quarterfor the first time

Shree Cement

Shree Cement reported revenue of Rs.4,801 cr., up 5% year on year and down 1% quarter on quarter. It reported operating profit of Rs.947 cr. and margin of 20%. Its net profit stood at Rs.268 cr. from a profit of Rs.194 cr. in the previous year and a profit of Rs.310 cr. In previous quarter.

Sarda Energy & Minerals

Sarda Energy & Minerals reported revenue of Rs.1,276 cr., down 3% year on year and down 16% quarter on quarter. It reported operating profit of Rs.311 cr. and margin of 24%. Its net profit stood at Rs.190 cr. from a profit of Rs.200 cr. in the previous year and a profit of Rs.328 cr. In previous quarter.

India Shelter Finance

India Shelter Finance announced strong financial results for Q3 FY26, with NII climbing 38.3% YoY to Rs 197 crore and Profit After Tax (PAT) surging 29.1% YoY to Rs 124 crore. The company’s board also approved the issuance of Non-Convertible Debentures (NCDs) worth up to Rs 1000 crores to bolster funding, alongside a re classification of certain promoter members to the public category.

TVS Motor Company

TVS Motor Company launched the TVS Ronin Top and TVS Ntorq Race Edition in Egypt on February 07, 2026, strengthening its market presence through a strategic partnership with authorized distributor Ezz LCV.

Whirlpool India

Whirlpool of India Ltd reported 39.55% dip in consolidated net profit to Rs 26.92 crore in Q3FY26, on account of the impact of new labour codes and higher expenses. The company had posted a consolidated net profit of Rs 44.53 crore in Q3FY25. Consolidated revenue from operations in the third quarter stood at Rs 1,773.84 crore as against Rs 1,704.85 crore in Q3FY25

Shipping Corporation of India

Shipping Corporation of India reported revenue of Rs.1,612 cr., up 22% year on year and up 20% quarter on quarter. It reported operating profit of Rs.678 cr. and margin of 42%. Its net profit stood at Rs.405 cr. from a profit of Rs.76 cr. in the previous year and a profit of Rs.189 cr. In previous quarter.

Crompton Greaves Consumer

Crompton Consumer reported a net profit of Rs 101 crore, lower than Rs 112 crore recorded in the year-ago period, marking a 9.8% decline. Revenue rose 7.3% year-on-year to Rs 1,898 crore, surpassing estimates of Rs 1,864 crore and compared with Rs 1,769 crore a year earlier

Sula Vineyards

Sula Vineyards Ltd., reported a sharp decline in net profit for the fifth consecutive quarter in Q3FY26. The company attributed the weak quarter—marked by a drop in revenue and EBITDA—to one time tactical destocking in Karnataka, its second-largest market. Net profit fell 67.5% year-on-year to Rs 9.1 crore, compared with Rs 28 crore in Q3FY26. Revenue for the quarter declined 9.6% YoY to Rs 195.7 crore, down from Rs 216.6 crore a year ago. Operating performance also weakened sharply, with EBITDA dropping 40.2% YoY to Rs 31.8 crore, compared with Rs 52.2 crore in the year-ago quarter.

Reliance Industries

Reliance Consumer Products, the FMCG subsidiary of Reliance Industries, has acquired a majority stake in Australia’s popular “better-for-you” beverage company, Goodness Group Global (GGG). Under the strategic partnership, Reliance Consumer Products will help promote Goodness Group’s flagship healthy beverage brands, such as Nexba and PACE—a hydration brand co-created with Australian cricket captain Pat Cummins—across new markets, including India.

Ipca Labs

The company’s Active Pharmaceutical Ingredients (API) manufacturing facility at Tarapur (Palghar, Maharashtra) has received the Establishment Inspection Report, classifying the facility as Voluntary Action Indicated (VAI). This indicates that the facility is in a minimally acceptable state of compliance with current good manufacturing practices (CGMP). The US FDA inspected the said manufacturing facility from December 1 and December 5, 2025.

Force Motors

The company has executed a Memorandum of Understanding to acquire 100 percent equity shares in Veera Tanneries for Rs 175 crore, subject to the deduction of applicable taxes.

Power Finance Corporation, REC

Following the in-principle approval of the Cabinet Committee on Economic Affairs (CCEA), Power Finance Corporation (PFC) has acquired 52.63 percent of the government’s shareholding in REC. Accordingly, PFC and REC are now operating as holding and subsidiary companies. The Board of Directors of PFC took note of the Budget announcement and accorded its in-principle approval for restructuring in the form of a merger between PFC and REC, while ensuring that the merged entity continues to remain a government company

Tata Chemicals

The company has announced an investment of Rs 515 crore to set up a new greenfield manufacturing facility in Tamil Nadu as part of its capacity expansion and supply-chain strengthening strategy. The facility will manufacture iodised vacuum salt dried (IVSD) and will have an installed capacity of 210 kilo tonnes per annum (KTPA).

Aurobindo Pharma

The United States Food and Drug Administration (US FDA) inspected Unit III, a formulation manufacturing facility of Eugia Pharma Specialities a wholly owned subsidiary of the company—at Pashamylaram, Telangana, from January 27 to February 6. The inspection concluded with 11 observations, which the company said are procedural in nature.

BEML

The Board has approved an estimated investment of approximately Rs 1,500 crore for a greenfield rail manufacturing facility, ‘BRAHMA’, at Umariya in Madhya Pradesh. The project is expected to be completed in a phased mannerover five years.

IREDA

The Board has approved raising funds of up to Rs 2,994 crore through a Qualified Institutions Placement (QIP) in one or more tranches, provided that the government’s shareholding—acting through the Ministry of New and Renewable Energy—does not dilute by more than 3.76 percent of the post-issue paid-up equity share capital of the company.

Mahindra & Mahindra

Mahindra Industrial Park Chennai (MIPCL), a joint venture between Mahindra World City Developers and Japan’s Sumitomo Corporation, has announced the commencement of operations of Mitsubishi Electric India’s air-conditioner and compressor manufacturing facility at Origins by Mahindra in Chennai. Developed with an investment of Rs 2,100 crore, the facility underscores Mitsubishi Electric India’s long-term commitment to the Indian market

Source: HSL Prime Daily, 09 Feb 2026